Work

Supplementary Figure 1 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers

Year: 2023

Type: supplementary-materials

Abstract: Chemical structure of drugs that inhibit metabolic enzymes FASN (AZ22), ACC (AZ52), DGAT (AZ17), PDHK (AZ30), and cell signalling kinase enzymes PI3K (AZ46), AKT (AZ28) and mTOR (AZ64).

DOI: 10.1158/1535-7163.22508377

Authors: Dylan T. Jones, Alessandro Valli, Syed Haider, Qifeng Zhang, Elizabeth A. Smethurst, Zachary T. Schug, Barrie Peck, Eric O. Aboagye, Susan E. Critchlow, Almut Schulze, Eyal Gottlieb, Michael J.O. Wakelam, Adrian L. Harris

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362528317

Cites:

Cited by:

Related to: 10